Clinical Trials Logo
  1. Home
  2. Lung Cancer Stage II
  3. NCT04970043

Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment

Lung Cancer Stage II Clinical Trial

Official title:
A Single Arm, Prospective, and Exploratory Clinical Study of Camrelizumab Combined With Pemetrexed and Carboplatin in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutation Who Failed EGFR-TKI Treatment

Clinical Trial Summary

A single-arm, prospective, single-center, phase II, exploratory study investigating Camrelizumab combined with pemetrexed and carboplatin in the treatment of advanced non-squamous cell non-small-scale EGFR mutations (EGFR-TKI treatment failure ) Effectiveness of cell lung cancer patients

Clinical Trial Description

In this study, eligible subject will be Subjects will have the opportunity to receive the treatment of Camrelizumab in combination with pemetrexed and carboplatin therapy . ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04970043
Study type Interventional
Source Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Contact lin Lin, doctor
Phone 13910388770
Email doctor.linlin@outlook.com
Status Not yet recruiting
Phase N/A
Start date July 31, 2021
Completion date July 30, 2024
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04305613 - Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy
Not yet recruiting NCT04108013 - A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC Phase 2
Not yet recruiting NCT04375566 - Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II
Not yet recruiting NCT06060964 - Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management Early Phase 1
Recruiting NCT04991025 - Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery Phase 2
Active, not recruiting NCT03322072 - Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating N/A
Active, not recruiting NCT03141359 - Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC Phase 2
Recruiting NCT03290534 - Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® Phase 2
Recruiting NCT05281237 - Avecure Flexible Microwave Ablation Probe For Lung Nodules N/A
Terminated NCT03984019 - Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis N/A
Recruiting NCT05258448 - COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)